TNF-α induces proliferation or apoptosis in human saphenous vein smooth muscle cells depending on phenotype

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Wang, Zhongbiao ^a   Rao, Pulipaka J ^a   Castresana, Manuel R ^a,b   Newman, Walter H ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Atherosclerosis; Cycloheximide; Epithelioid; Spindle; Stenosis; Tumor necrosis factor

Indexed keywords

CASPASE 3; CELL DNA; CYCLOHEXIMIDE; DNA FRAGMENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVATION; EPITHELIOID CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RESTENOSIS; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; SPINDLE CELL;

APOPTOSIS; CASPASE 3; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYCLOHEXIMIDE; ENZYME ACTIVATION; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; SAPHENOUS VEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 11144347760     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00165.2004     Document Type: Article

References (54)

1. Bar H, Bea F, Blessing E, Watson L, Wende P, Kreuzer J, Kubler W, and Jahn L. Phosphorylation of cytokeratin 8 and 18 in human vascular smooth muscle cells of atherosclerotic lesions and umbilical cord vessels. Basic Res Cardiol 96: 50-58, 2001.
2. Bascands JL, Girolami JP, Troly M, Escargueil-Blanc I, Nazzal D, Salvayre R, and Blaes N. Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells. Hypertension 38: 1294-1299, 2001.
3. Battegay EJ, Raines EW, Colbert T, and Ross R. TNF-α stimulation of fibroblast proliferation. J Immunol 154: 6040-6047, 1995.
4. + exchange. J Clin Invest 83: 822-829, 1989.
5. Beyaert R, Van Loo G, Heyninck K, and Vandenabeele P. Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int Rev Cytol 214: 225-272, 2002.
6. Chen G and Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635, 2002.
7. Christiansen JF, Hartwig D, Bechtel JF, Kluter H, Sievers H, Schonbeck U, and Bartels C. Diseased vein grafts express elevated inflammatory cytokine levels compared with atherosclerotic coronary arteries. Ann Thorac Surg 77: 1575-1579, 2004.
8. Clausell N, Molossi S, Sett S, and Rabinovitch M. In vivo blockade of tumor necrosis factor-α in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation. Circulation 89: 2768-2779, 1994.
9. Denizot F and Lang R. Rapid colorimetric assay for cell growth and survival. J Immunolog Method 89: 271-277, 1986.
10. 2 angiotensin receptors in apoptosis in rat blood vessels. Hypertension 34: 617-624, 1999.
11. Geng YJ, Azuma T, Tang JX, Hartwig JH, Muszynski M, Wu Q, Libby P, and Kwiatkowski DJ. Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. Eur J Cell Biol 77: 294-302, 1998.
12. Geng YJ, Hansson GK, and Holmes E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 71: 1268-1276, 1992.
13. Geng YJ and Libby P. Evidence of apoptosis in advanced human atheroma. Colocalization with interleukin-1-β-converting enzyme. Am J Pathol 147: 267-277, 1995.
14. Geng YJ and Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Bio 22: 1370-1380, 2002.
15. Geng YJ, Wu Q, Muszynski M, Hansson GK, and Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler Throm Vasc Biol 16: 19-27, 1996.
16. Gimona M, Herzog M, Vandekerckhove J, and Small JV. Smooth muscle specific expression of calponin. FEBS Lett 274: 159-162, 1990.
17. Glukhova MA, Frid MG, and Koteliansky VE. Phenotypic changes of human aortic smooth muscle cells during development and in the adult vessel. Am J Physiol 261 Suppl 4: 78-80, 1991.
18. Hao H, Gabbiani G, and Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23: 1510-1520, 2003.
19. Hoshi S, Goto M, Koyama N, Nomoto KI, and Tanaka H. Regulation of smooth muscle cell proliferation by nuclear factor-κB and its inhibitor, IκB. J Biol Chem 275: 883-889, 2000.
20. Isner JM, Knearney M, Bortman S, and Passeri J. Apoptosis in athrosclerosis and restenosis. Circulation 91: 2703-2711, 1995.
21. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, and Nilsson J. Tumor necrosis factor-α activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 17: 490-497, 1997.
22. Kenagy RD and Clowes AW. Blockade of smooth muscle cell migration and proliferation in baboon aortic explants by interleukin-1β and tumor necrosis factor-α is nitric oxide-dependent and nitric oxide-independent. J Vasc Res 37: 381-389, 2000.
23. Kockx MM, Cambier BA, Bortier HE, De Meyer GR, Declercq SC, van Cauwelaert PA, and Bultinck J. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histopathology 25: 365-371, 1994.
24. Kuro-o M, Nagai R, Tsuchimochi H, Katoh H, Yazaki Y, Ohkubo A, and Takaku F. Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem 264: 18272-18275, 1989.
25. Li S, Fan YS, Chow LH, Van Den Diepstraten C, van Der Veer E, Sims SM, and Pickering JG. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ Res 89: 517-525, 2001.
26. Libby P and Clinton SK. Cytokines as mediators of vascular pathology. Nouv Rev Fr Hematol 34 Suppl: S47-S53, 1992.
27. Mayr U, Mayr M, Li C, Wernig F, Dietrich H, Hu Y, and Xu Q. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Circ Res 90: 197-204, 2002.
28. Morisaki N, Xu QP, Koshikawa T, Saito Y, Yoshida S, and Ueda S. Tumor necrosis factor-α can modulate the phenotype of aortic smooth muscle cells. Scand J Clin Invest 53: 347-352, 1993.
29. Motwani JG and Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97: 916-931, 1998.
30. Nakamura M, Tanaka M, Abe S, and Fujiwara H. Sudden pressure elevation can trigger acute muscle cell death of the heart and aorta. Atherosclerosis 146: 25-32, 1999.
31. Newman WH, Castresana MR, Webb JG, and Wang Z. Cyclic AMP inhibits TNF-α-induced smooth muscle cell migration and IL-6 expression. J Surg Res 109: 57-61, 2003.
32. Obara H, Takayanagi A, Hirahashi J, Tanaka K, Wakabayashi G, Matsumoto K, Shimazu M, Shimizu N, and Kitajima M. Overexpression of truncated IκBα induces TNF-α-dependent apoptosis in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 2198-2204, 2000.
33. Pohlman TH and Harlan JM. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 119: 41-52, 1989.
34. Pollman MJ, Yamada T, Horiuchi M, and Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis: counter-vailing influences of nitric oxide and angiotensin II. Circ Res 79: 748-756, 1996.
35. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, and Ozaki CK. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102: 1697-1702, 2000.
36. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999.
37. Rus HG, Niclescu F, and Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 89: 247-254, 1991.
38. Selzman CH, Shames BD, McIntyre RC Jr, Banerjee A, and Harken AH. The NF-κB inhibitory peptide, IκBα, prevents human vascular smooth muscle proliferation. Ann Thorac Surg 67: 1227-1231, 1999.
39. Selzman CH, Shames BD, Reznikov LL, Miller SA, Meng X, Barton HA, Werman A, Harken AH, Dinerallo CA, and Banerjee A. Liposomal delivery of purified inhibitory-κBα inhibits tumor necrosis factor-α-induced human vascular smooth muscle proliferation. Circ Res 84: 867-875, 1999.
40. Shanahan CM and Weissberg PL. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 18: 333-338, 1998.
41. Sheikh MS, Huang Y. Death receptor activation complexes: it takes two to activate TNF receptor I. Cell Cycle 2: 550-552, 2003.
42. Tanaka H, Swanson SJ, Sukova G, Schoen FJ, and Libby P. Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-α and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol 147: 617-626, 1995.
43. Thornberry NA. Interleukin-1 beta converting enzyme. Methods Enzymol 244: 615-631, 1994.
44. Varfolomeev EE, Boldin MP, Goncharov TM, and Wallach D. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domain of the two receptors also bind to each other. J Exp Med 183: 1271-1275, 1996.
45. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, and Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17: 331-367, 1999.
46. Wang CY, Mayo MW, and Baldwin AS. TNF-α and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274: 784-789, 1996.
47. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, and Baldwin AS. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683, 1998.
48. Wang Z, Castresana MR, Detmer K, and Newman WH. An IκB-α mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. J Surg Res 102: 198-206, 2002.
49. Wang Z, Castresana MR, and Newman WH. NF-κB is required for TNF-α-directed smooth muscle cell migration. FEBS Lett 508: 360-364, 2001.
50. Wang Z, Castresana MR, and Newman WH. Reactive oxygen species-sensitive p38 MAPK controls thrombin-induced migration of smooth muscle cells. J Mol Cell Cardiol 36: 49-56, 2004.
51. Xu Y, Bialik S, Jones BE, Iimuro Y, Kitsis RN, Srinivasan A, Brenner DA, and Czaka MJ. NF-κB inactivation converts a hepatocyte cell line TNF-α response from proliferation to apoptosis. Am J Physiol Cell Physiol 275: C1058-C1066, 1998.
52. Yamada T, Akishita M, Pollman MJ, Gibbons GH, Dzau VJ, and Horiuchi M. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type I receptor action: an in vitro gene transfer study. Life Sci 63: PL289-PL295, 1998.
53. Yan Z and Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 82: 21-29, 1998.
54. Zhang X and Morrison DC. Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production in mouse peritoneal macrophages. J Immunol 150: 1011-1018, 1993.